A new study by a University of South Florida researcher found important revelations that could provide chain-operated nursing homes with crucial implications for operational goals and strategic findings that carry over to other service industries. The biggest takeaway for nursing home operators is that having a similar percentage of Medicaid patients among its mix of residents while having a staff […]
When a person nearing the end of their life enters hospice care, their hospice agency’s doctors may prescribe a “comfort kit” of small amounts of medications that their caregivers can give them in case of urgent, distressing symptoms such as severe anxiety, agitation, delirium, nausea and more. They may also get other prescriptions as their hospice care goes on. But […]
Heart transplantation can be a lifesaving operation for patients with end-stage heart failure. However, many patients experience organ transplant rejection, in which the immune system begins attacking the transplanted organ. But detecting transplant rejection is challenging — in its early stages, patients may not experience symptoms, and experts do not always agree on the degree and severity of the rejection. […]
Only 20 percent of patients being treated in the hospital for severe stroke received a palliative care consultation, and only 43 percent of patients who died in the hospital met with a palliative care team, according to a new study from Regenstrief Institute and Indiana University. Study authors believe more people should be receiving these consultations that outline care options, […]
BeiGene has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of BRUKINSA (zanubrutinib) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM) who have received at least one prior therapy or first-line treatment for patients unsuitable for chemo-immunotherapy. “Bruton’s tyrosine kinase (BTK) inhibitors have […]
Recent Comments